Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury

References

• Arnould T, Vankoningsloo S, Renard P, et al. (2002). CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J 21:53–63
   PubMed Web of Science ®Google Scholar
• Baines CP. (2009). The mitochondrial permeability transition pore and ischemia–reperfusion injury. Basic Res Cardiol 104:181–8
   PubMed Web of Science ®Google Scholar
• Baines CP, Kaiser RA, Sheiko T, et al. (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9:550–5
   PubMed Web of Science ®Google Scholar
• Barancik M, Htun P, Strohm C, et al. (2000). Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol 35:474–83
   PubMed Web of Science ®Google Scholar
• Berkich DA, Salama G, Lanoue KF. (2003). Mitochondrial membrane potentials in ischemic hearts. Arch Biochem Biophys 420:279–86
   PubMed Web of Science ®Google Scholar
• Bogoyevitch MA, Gillespie BJ, Ketterman AJ, et al. (1996). Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79:162–73
   PubMed Web of Science ®Google Scholar
• Bulavin DV, Saito S, Hollander MC, et al. (1999). Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18:6845–54
   PubMed Web of Science ®Google Scholar
• Cesura AM, Pinard E, Schubenel A, et al. (2003). The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J Biol Chem 278:49812–18
   PubMed Web of Science ®Google Scholar
• Clark JR, Sarafraz N, Marber MS. (2007). Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacol Ther 116:192–206
   PubMed Web of Science ®Google Scholar
• Di Lisa F, Canton M, Memabo R, et al. (2007). Mitochondria and cardioprotection. Heart Fail Rev 12:249–60
   PubMed Web of Science ®Google Scholar
• Gottlieb RA. (2011). Cell death pathways in acute ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 16:233–8
   PubMed Web of Science ®Google Scholar
• Gottlieb RA, Burleson KO, Kloner RA, et al. (1994). Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621–8
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. (1998). Mitochondria and apoptosis. Science 281:1309–12
   PubMed Web of Science ®Google Scholar
• Halrestrap AP, Clarke SJ, Javadov SA. (2004). Mitochondrial permeability transition pore opening during myocardial reperfusion – A target for cardioprotection. Cardiovasc Res 61:372–85
   PubMed Web of Science ®Google Scholar
• Hsu MJ, Hsu CY, Chem BC, et al. (2007). Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci 27:5719–29
   PubMed Web of Science ®Google Scholar
• Jennings RB, Ganote CE. (1976). Mitochondrial structure and function in acute myocardial ischemic injury. Circ Res 38:I80–91
   Web of Science ®Google Scholar
• Kim YA, Kim MY, Yu HY, et al. (2013). Gadd45beta is transcriptionally activated by p53 via p38alpha-mediated phosphorylation during myocardial ischemic injury. J Mol Med (Berl) 91:1303–13
   PubMed Web of Science ®Google Scholar
• Kimura H, Shintani-ishida K, Nakajima M, et al. (2006). Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia. Life Sci 78:1901–10
   PubMed Web of Science ®Google Scholar
• Krijnen PA, Nijmeijer R, Meijer CJ, et al. (2002). Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 55:801–11
   PubMed Web of Science ®Google Scholar
• Kumphune S, Bassi R, Jacquet S, et al. (2010). A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580. J Biol Chem 285:2968–75
   PubMed Web of Science ®Google Scholar
• Kumphune S, Chattipakorn S, Chattipakorn N. (2012). Role of p38 inhibition in cardiac ischemia/reperfusion injury. Eur J Clin Pharmacol 68:513–24
   PubMed Web of Science ®Google Scholar
• Larsen JK, Yamboliev IA, Weber LA, Gerthoffer WT. (1997). Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle. Am J Physiol 273:L930–40
   PubMedGoogle Scholar
• Li L, Tao JJ, Davaille J, et al. (2001). 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J Biol Chem 276:38152–8
   PubMed Web of Science ®Google Scholar
• Lochner A, Marais E, Genade S, et al. (2009). Protection of the ischaemic heart: Investigations into the phenomenon of ischaemic preconditioning. Cardiovasc J Afr 20:43–51
   PubMed Web of Science ®Google Scholar
• Lundberg KC, Szweda LI. (2004). Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch Biochem Biophys 432:50–7
   PubMed Web of Science ®Google Scholar
• Lv X, Wan J, Yang J, et al. (2008). Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia–reperfusion. Eur J Pharmacol 596:118–26
   PubMed Web of Science ®Google Scholar
• Mcenery MW, Snowman AM, Trifiletti RR, Snyder SH. (1992). Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 89:3170–4
   PubMed Web of Science ®Google Scholar
• Murphy KM, Ranganathan V, Farnsworth ML, et al. (2000). Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 7:102–11
   PubMed Web of Science ®Google Scholar
• O'Rouke B. (2000). Pathophysiological and protective roles of mitochondrial ion channels. J Physiol 529:23–36
   PubMed Web of Science ®Google Scholar
• Perfettini JL, Castedo M, Nardacci R, et al. (2005). Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 201:279–89
   PubMed Web of Science ®Google Scholar
• Premkumar A, Simantov R. (2002). Mitochondrial voltage-dependent anion channel is involved in dopamine-induced apoptosis. J Neurochem 82:345–52
   PubMed Web of Science ®Google Scholar
• Saikumar P, Dong Z, Weinberg JM, Vemkatachalam MA. (1998). Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17:3341–9
   PubMed Web of Science ®Google Scholar
• Schwertz H, Carter JM, Abdudureheman M, et al. (2007). Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics 7:4579–88
   PubMed Web of Science ®Google Scholar
• Singhal PC, Bhaskaran M, Patel J, et al. (2002). Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 168:4025–33
   PubMed Web of Science ®Google Scholar
• Son KN, Pugazhenthi S, Lipton HL. (2009). Activation of tumor suppressor protein p53 is required for Theiler's murine encephalomyelitis virus-induced apoptosis in M1-D macrophages. J Virol 83:10770–7
   PubMed Web of Science ®Google Scholar
• Surinkaew S, Kumphune S, Chattipakorn S, Chattipakorn N. (2013). Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart. J Cardiovasc Pharmacol 61:133–41
   PubMed Web of Science ®Google Scholar
• Tanno M, Bassi R, Gorog DA, et al. (2003). Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: Evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93:254–61
   PubMed Web of Science ®Google Scholar
• Thornton TM, Rincon M. (2009). Non-classical p38 map kinase functions: Cell cycle checkpoints and survival. Int J Biol Sci 5:44–51
   PubMed Web of Science ®Google Scholar
• Thummasorn S, Kumfu S, Chattipakorn S, Chattipakorn N. (2011). Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion 11:457–66
   PubMed Web of Science ®Google Scholar
• Vaseva AV, Marchenko ND, Ji K, et al. (2012). p53 Opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149:1536–48
   PubMed Web of Science ®Google Scholar
• Ward KW, Prokscht JW, Azzaranot LM, et al. (2001). Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase. Xenobiotica 31:783–97
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2008). World Heath Statistics 2008 [Online]. Available from: http://www.who.int/entity/whosis/whostat/EN_WHS08_Full.pdf [last accessed 19 Apr 2014]
   Google Scholar